American Journal of Transplantation

Article	Citations
Kaposi sarcoma herpesvirus inflammatory cytokine syndrome—a severe complication of an overlooked donor-derived infection	281
Incidental peritoneal and hepatic lesions in a living kidney donor candidate	281
Induction of immune tolerance in living related human leukocyte antigen–matched kidney transplantation: A phase 3 randomized clinical trial	280
Long-term outcomes at 5 years posttransplant in imlifidase-desensitized kidney transplant patients	267
Treatment of rapid recurrence of severe steatosis with combined glucagon-like peptide-1 agonist and growth hormone therapy in a pediatric patient transplanted for metabolic dysfunction-associated stea	200
Letter in reference to “Association of Procurement Technique with Organ Yield and Cost Following Donation After Circulatory Death”	180
Transfusion-specific alloimmune responses following blood transfusion pre–kidney transplantation	179
Impact of repeat human leukocyte antigen mismatches on kidney graft survival: A contemporary Collaborative Transplant Study analysis	159
Finding actionable information in the universe of data	150
DCDD HEART TRANSPLANTATION WITH THORACO-ABDOMINAL NORMOTHERMIC REGIONAL PERFUSION AND STATIC COLD STORAGE: THE EXPERIENCE IN SPAIN	136
Complement inhibition alleviates donor brain death-induced liver injury and posttransplant cascade injury by regulating phosphoinositide 3-kinase signaling	129
An uncommon complication after living donor nephrectomy	119
Erratum to The impact of time to death in donors after circulatory death on recipient outcome in simultaneous pancreas-kidney transplantation [American Journal of Transplantation 24 (2024) 1247–1256]	115
Terminally differentiated effector memory T cells in kidney transplant recipients: New crossroads	114
Immunomodulation of T cell-mediated alloimmunity by proximity to endothelial cells under the mammalian target of rapamycin blockade	113
ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation	112
Out-of-sequence allocation: a necessary innovation or a new inequity in transplantation?	108
Murine kidney transplant outcome is best measured by transdermal glomerular filtration rate	106
OPTN/SRTR 2021 Annual Data Report: COVID-19	102
The first 4-way liver paired exchange from an interdisciplinary collaboration between health care professionals and design economists	101
Eplet mismatch imputation studies should include immunologic risk assessment	101
Microbiota and immunoregulation: A focus on regulatory B lymphocytes and transplantation	96
Interleukin-2 and PD-1 synergistically modify T cell exhaustion programs	94
Third-party bone marrow–derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial	90
Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study	89

OPTN/SRTR 2021 Annual Data Report: Pancreas	89
Mesenchymal stromal cell treatment of donor kidneys during ex vivo normothermic machine perfusion: A porcine renal autotransplantation study	84
Preservation of pancreas in the University of Wisconsin solution supplemented with AP39 reduces reactive oxygen species production and improves islet graft function	84
Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave	80
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients	78
Donor Graft Steatosis Is Associated with Intrahepatic Hepatocellular Carcinoma Recurrence Following Liver Transplantation	75
Temporal changes in BMI and outcomes in liver transplantation	73
10°C static storage mitigates ischemia reperfusion injury through improved mitochondrial preservation in a porcine DCD liver model	73
Effects of Anti-PD-L1 or IL-15/IL-15Ra-Fc Complex Treatment on CD4-independent CD8+ T Cell-Mediated Skin Allograft Rejection	72
The Utility of LDH as an Early Biomarker of Kidney Graft Function	72
Alpha-Gal-KO Xenothymokidney Response to Endogenous Arginine Vasopressin in a Living Human Recipient with a Durable Mechanical Circulatory Support Device	70
Dual Kidney Transplantation from Extended Marginal Donors in the United States: An analysis of SRTR and Literature Review	69
Beyond Functional Warm Ischemia Time in Donation After Circulatory Death Kidney Allograft Evaluation	69
Public perceptions of organ donation by determination of death and procurement technique	69
Long-term outcomes of pediatric hepatoblastoma patients who present with metastasis and receive liver transplantation	66
Utility of Donor Derived Cell Free DNA Testing in Pancreas Transplantation Patients	65
Pediatric Survival on the Heart Transplant Waiting List	64
It’s Getting Better All the Time: Decreased Cumulative Incidence of Waitlist Mortality in Pediatric Candidates Following 2018 Heart Allocation Policy Change	64
One-Year Creatinine Predicts Long-Term Graft Survival In Pediatric Kidney Transplant Recipients	64
Outcomes By Epstein-Barr Virus Serostatus In Pediatric Kidney Transplantation	64
Early Response of Histotripsy for Liver Tumors	62
The Acceptability of a Caregiver-Directed Animated Video about Kidney Transplant Navigation	62
Expedited Placement of Late-Turndown Livers - Efficiency at the Price of Equity?	61
Role of Proton Beam Radiotherapy (PBRT) in Downstaging or Bridging Patients with Hepatocellular Carcinoma (HCC) prior to Liver Transplantation (LT)	61
Opioid Use in Laparoscopic vs Robotic Donor Nephrectomy	61
Benefits Of Preemptive Transplantation In Older Patients with High KDPI Kidneys: Is Sooner Better Than Later?	61
Priority for Prior Living Kidney Donors and Trends in Waiting Times According to Race	60
Rethinking Lactate’s Role as a Post-Transplant Outcome Predictor During Normothermic Machine Perfusion: Science or Speculation?	60
Deceased Kidney Donors on Dialysis Create Opportunities for Renal Transplantation: A Single Center Experience	60
ABO incompatible living donor liver transplant novel immunosuppression regimen: a case series report	60
Impact of NRP on Simultaneous Kidney Pancreas Transplant: A Markov Decision Analysis	59
UNRAVELING SOCIAL FACTORS EXISTING BETWEEN DONOR-RECIPIENT PAIRINGS IN LIVING DONOR LIVER TRANSPLANTATION	58
Integrating Robotics into Transplant Fellowships: Shaping the Next Generation of Transplant Surgeons	58
Increasing Circulator Hand-offs is Independently Associated with 90-Day Complications after Liver Transplant	58
Optimization of donor flow matching and portal modulation to decrease small for size syndrome in Living Donor Liver Transplant - A Single Center American Experience	58
Longitudinal Assessment of Solid Organ Transplant Recipients with SARS-CoV-2	58
Geographic Variation in Utilization of Normothermic Machine Perfusion for Liver Transplantation	57
Early Versus Standard Liver Transplantation for Alcohol-Associated Liver Disease in High-Acuity Liver Transplant Recipients	57
Evaluation of 2- versus 3-Point Timed Measurements of Plasma Iohexol Clearance in Kidney Transplant Donors	56
Is an Implantable Doppler Probe useful as a vascular monitoring device in kidney transplant patients? A retrospective cohort, single- centre study	56
To Transplant or Not to Transplant?: High Risk Factors in AKI Stage III Donor Kidney Transplants	55
Increasing Access to DCD Liver Transplant via Perfusion Technology: Time is On Our Side	52
Kidnaey Transplant Recipient Reported Quality of Life Is Associated with Overall Graft Function	52
Exploring Machine Learning Algorithms to Revise the Kidney Donor Risk Index	52
Effect of Donor-Recipient Age Difference on Liver Transplant Outcomes	50
Intestine Re-Transplantation is Associated with Lower Graft Survival: A UNOS Database Study	50
How hard are the hard outcomes reported in national transplant registries?	49
Emerging Multidrug-Resistant Salmonella Strain in United States	49
Obesity, organ failure, and transplantation: A review of the role of metabolic and bariatric surgery in transplant candidates and recipients	49
The urgent need for standardization in liver transplantation for unresectable colorectal liver metastases in the United States	49

Pancreas irradiation for treatment-resistant acute cellular rejection in a severely immunocompromised pancreas-after-kidney transplant recipient—case report	49
Increasing Azole-resistant environmental Aspergillus fumigatus in Denmark	49
Gingival hypertrophy in a kidney transplant recipient	48
MICA is a histocompatibility antigen in transplantation	47
Buyer beware: The risks of donor-derived vaccine-induced thrombosis and thrombocytopenia	47
Letter to the Editor in reply to: “Hardest-to-place kidney transplant outcomes in the United States” (published in: Am J Transplant 2021; 21:3663-3672.)	47
Response to “SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients”	47
Outbreaks associated with treated recreational water — United States, 2015–2019	47
	46
Response to “COVID-19 in SOT versus non-SOT”	46
	46
	46
Reply to Angeletti et al—Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis	46
ATC 2023 Table of Contents	45
Program	45
Program	45
T cell–mediated rejection in kidney transplant recipients: The end(point) is also the beginning	45
OFC 23rd Winter Symposium	44
Addition of interleukin-6 receptor blockade to carfilzomib-based desensitization in a highly sensitized nonhuman primate model	43
Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: Recommendations of the Advisory Committee on Immunization Practices—United States, 2022	43
Don’t stop thinking about tomorrow: Ascertainment bias in pre-post design transplant registry studies	43
Distinct association between chronic Epstein-Barr virus infection and T cell compartments from pediatric heart, kidney, and liver transplant recipients	43
Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study	42
The impact of cancer on the risk of death with a functioning graft of Italian kidney transplant recipients	42
COVID-19 in pediatric kidney transplantation: The Improving Renal Outcomes Collaborative	42
An international multicenter validation study of the Toronto listing criteria for pediatric intestinal transplantation	42
Successful treatment of Epstein–Barr virus–associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third-party Epstein–Barr viru	42
Live virus vaccination following pediatric liver transplantation: Outcomes from two academic children’s hospitals	42
ATC 2024 Oral Abstracts	42
Combined heart liver transplantation in the patients with advanced liver disease and/or hepatocellular carcinoma: Why cannot liver pull the heart?	40
Association between acute graft pyelonephritis and kidney graft survival: A single-center observational study	40
SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients	40
Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient	40
Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study	39
Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidates	39
Eculizumab as a therapeutic approach for severe crescentic recurrence of immunoglobulin A nephropathy after kidney transplantation	39
Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma	39
Induction of fetomaternal tolerance? Suppressing B cells!	39
Phage-display immunoprecipitation for precision mapping the autoreactome	38
Persistent abdominal pain in kidney transplant recipient	38
Dawn has arrived, illuminating thrilling opportunities and fresh challenges in a new era of United States transplantation	38
Tenosynovitis in a renal transplant recipient: Making the diagnosis firsthand	38
Executive orders prohibiting vaccine mandates: Implications for transplant patients and physicians	38
AJT Digest for Patients: Their Own Window into Key Research	37
Polymicrobial bacteremia in a heart transplant recipient: More than what meets the eye	37
Quantitative assessment of portal jump graft inflow following liver transplantation using 4D flow MRI	37
An ethical analysis of obesity as a contraindication to pediatric liver transplant candidacy	37
Natural killer cells are under new Nogo control	36
ATC 2024 Keyword Index	36
Mortality in solid organ transplant recipients hospitalized for COVID-19	35
Interim effectiveness of the updated 2023-2024 COVID-19 vaccines in adults with immunocompromizing conditions	35
Short- and long-term complications after living donor ileal resection	35
Association between cytomegalovirus viremia and long-term outcomes in lung transplant recipients	35
American Journal of Transplantation: Volume 22, Number 7, July 2022	34
Semi-direct alloantigen presentation detected in human liver but not kidney transplant recipients: Implications for the future	34
	34
Allograft rejection: Be aware of tissue-resident T cells	34
Letter to the editor in response to: Measuring success in pig to non-human-primate renal xenotransplantation: Systematic review and comparative outcomes analysis of 1051 life sustaining NHP renal allo	34
American Journal of Transplantation: Volume 21, Number 4, April 2021	33
Sex Disparity in Transplant: A Problem Hiding in Plain Sight	33
Ethical challenges of organ transplantation: Current debates and international perspectivesSolveig Lena Hansen and Silke Schicktanz (Eds.) Transcript Publishing, 2021, 358 Pages	33
Hematochezia: A late complication after pancreas transplantation	33
Senescence and aging of solid organs? Blame the immune system!	33
Comment – Bold policy changes are needed to meet the need for organ transplantation in India	33
American Journal of Transplantation: Volume 21, Number 7, July 2021	33
Dissecting CMV latency and reactivation: BETing on the epigenetic regulators	32
Response to “The real number of organs from uncontrolled donation after circulatory determination of death donors”	32
Post-mortem molecular investigations of SARS-CoV-2 in an unexpected death of a recent kidney transplant recipient	32
Vaccine mandates: A transplant recipient’s perspective	32
The Rochester Protocol for Living Donor Liver Transplantation of Unresectable Colorectal Liver Metastasis: A 5-Year Report on Selection, Approval, and Outcomes	32
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020	32
Liver graft outcomes from donors with vaccine induced thrombosis and thrombocytopenia (VITT): United Kingdom multicenter experience	31
Chronic gastrointestinal bleeding and anemia in a pancreas transplant recipient: A creative solution to a previously uncharacterized complication	31
Waning humoral immune response to the BNT162b2 vaccine in heart transplant recipients over 6 months	31
The role of endoscopy in the small intestinal transplant recipient: A review	31
Demystifying tolerance	31
Protection of liver sinusoids by intravenous administration of human Muse cells in a rat extra-small partial liver transplantation model	31
A complex puzzle realized: US achieves one-millionth organ transplant	31
Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor	31
Need for improvements in simultaneous heart-kidney allocation: The limitation of pretransplant glomerular filtration rate	30

Primary hyperoxaluria diagnosed after kidney transplant: A review of the literature and case report of aggressive renal replacement therapy and lumasiran to prevent allograft loss	30
A novel microsurgical reconstruction technique in a living-related liver donor hepatic artery dissection using the native hepatic artery	30
Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19	30
Fever, skin nodules, and hyperintense intramuscular leg lesions in a liver transplant patient	30
The new French kidney allocation system for donations after brain death: Rationale, implementation, and evaluation	30
Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients	30
Antiplasma cell antibodies: A new era of human leukocyte antigen antibody control in solid organ transplantation	29
Health care personnel exposures to subsequently laboratory-confirmed monkeypox patients — Colorado, 2022	29
Disparities in liver transplantation: One size may not fit all	29
Donor-derived myeloid leukemia	29
Simultaneous en bloc kidney and pancreas transplantation from pediatric donors: Selection, surgical strategy, management, and outcomes	29
Subthreshold rejection activity in many kidney transplants currently classified as having no rejection	29
Letter in reference to “Using machine learning for personalized prediction of longitudinal COVID-19 vaccine responses in transplant recipients”	28
Normal long-term neurologic and graft outcome after liver transplantation in an infant with Neimann-Pick type C disease	28
Neoadjuvant pemigatinib as a bridge to living donor liver transplantation for intrahepatic cholangiocarcinoma with FGFR2 gene rearrangement	28
Outside Front Cover	28
An ethical analysis of conditional and partially directed live kidney donation among strangers—The Israeli experience	28
Are we closer to abandoning protocol graft biopsies after pediatric liver transplantation?	28
Out-of-sequence allocation: It is useful, but is it ethical?	28
Tissue-resident memory T cells in human kidney transplants have alloreactive potential	27
Rationale for the IMAGINE study for chronic active antibody-mediated rejection (caAMR) in kidney transplantation	27
Cytokine storm induced by a PD1 inhibitor in a renal transplant patient	27
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients	27
Outside Front Cover	27
Generating strategies for a national comeback in pancreas transplantation: A Delphi survey and US conference report	27
Early β-lactam concentrations and infectious complications after lung transplantation	27
Avian Influenza: Protecting Our Canaries	27
Listing for blood type A2 donors is highly variable and impacts waitlist outcomes among blood type O liver transplantation candidates in the United States	26
Incorporating kidney-related multi-organ transplants into the kidney allocation sequence	26
OPTN/SRTR 2020 Annual Data Report: Intestine	26
Direct and indirect allorecognition—not so different after all?	26
Remembering pancreas transplantation as an option for patients with diabetes	26
Association between out-of-sequence allocation and deceased donor kidney nonuse across organ procurement organizations	26
Decreasing Efficiency in Deceased Donor Kidney Offer Notifications Under the New Distance-Based Kidney Allocation System	26
Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients	26
IgG3 donor–specific antibodies with a proinflammatory glycosylation profile may be associated with the risk of antibody-mediated rejection after kidney transplantation	26
COVID-19 after two doses of mRNA vaccines in kidney transplant recipients	25
Trends in nonfatal and fatal overdoses involving benzodiazepines—38 states and the District of Columbia, 2019–2020	25
Opinions vs evidence: data-driven insights into the organ yield and cost of normothermic regional perfusion in donation after circulatory death	25
T cells with stem cell-like properties mediate type 1 diabetes	25
Banff 2022 pancreas transplantation multidisciplinary report: Refinement of guidelines for T cell–mediated rejection, antibody-mediated rejection and islet pathology. Assessment of duodenal cuff biops	25
The suggestion of mitigating disparity in the liver transplantation field among ABO blood type	24
Ethical implications of prioritizing utility at all costs: The rise of out-of-sequence transplants	24
International multicenter study of ultralow graft-to-recipient weight ratio grafts in adult living donor liver transplantation	24
CD86 occupancy in belatacept-treated kidney transplant patients is not associated with clinical and infectious outcomes	24
BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia: A Swiss Transplant Cohort Study	24
New metrics to measure OPO performance are here: How do we ensure organizations receive feedback and improve organ donation?	24
Effect of nirmatrelvir/ritonavir on calcineurin inhibitor levels: Early experience in four SARS-CoV-2 infected kidney transplant recipients	23
Successful liver transplantation in patients with active SARS-CoV-2 infection	23
A collaborative stewardship of OPOs and transplant centers to maintain equitable allocation when facilitating ex vivo organ preservation	23
Accurate eplet identification is necessary for accurate risk assessment	23
Poster Abstracts	23
Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipients	23
C4 article: Implications of COVID-19 in transplantation	23
Influenza incidence and vaccine effectiveness during the Southern Hemisphere Influenza season—Chile, 2022	23
Donation after circulatory death in preterm infants	23
The Economy of Transplant: Saving Money and Saving Lives	23
A multi-institutional study of renal outcomes and renal-related pregnancy outcomes in uterus transplant recipients	23
Rate of recipient-derived alveolar macrophage development and major histocompatibility complex cross-decoration after lung transplantation in humans	23
miR-449a ameliorates acute rejection after liver transplantation via targeting procollagen-lysine1,2-oxoglutarate5-dioxygenase 1 in macrophages	22
Development and validation of the lung donor (LUNDON) acceptability score for pulmonary transplantation	22
Engineering pancreatic islets with a novel form of thrombomodulin protein to overcome early graft loss triggered by instant blood-mediated inflammatory reaction	22
Active immunologic participation and metabolic shutdown of kidney structural cells during kidney transplant rejection	22
Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation: A case report	22
Transplant Center Websites: Yet Another Barrier to Equitable Care?	22
Luminal polyethylene glycol solution delays the onset of preservation injury in the human intestine	22
Successful kidney transplantation from a deceased donor with severe COVID-19 respiratory illness with undetectable SARS-CoV-2 in donor kidney and aorta	22
TGR5/Cathepsin E signaling regulates macrophage innate immune activation in liver ischemia and reperfusion injury	22
Incidence of and risk factors for influenza-associated hospital encounters in pediatric solid organ transplant recipients	21
De novo membranous nephropathy in a pig-to-baboon kidney xenograft: A new xenograft glomerulopathy	21
Identifying and understanding variation in population-based access to liver transplantation in the United States	21
Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study	21
Liver transplantation for alcohol-associated liver disease: A call for national standards of best practices to monitor and bridge disparities in access and outcomes	21
The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients	21
Coordinated elimination of bacterial taxa optimally attenuates alloimmunity and prolongs allograft survival	21
T-cell receptor sequencing reveals selected donor-reactive CD8+ T cell clones resist antithymocyte globulin depletion after kidney transplantation	21
Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates	21
Diffuse calcification of pancreas impairs endocrine function and predicts poor outcome in total pancreatectomy with islet autotransplantation	21
Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival	21
Semidirected living donors in Israel: Sociodemographic profile, religiosity, and social tolerance	21
Development of an improved Scientific Registry of Transplant Recipients deceased donor heart yield model using donor critical care data from the Donor Management Goal Registry cohort	20
Consequences of low estimated glomerular filtration rate either before or early after kidney donation	20
Validation of a novel donor lung scoring system based on the updated lung Composite Allocation Score	20
Continuous glucose monitoring for the prediction of posttransplant diabetes mellitus and impaired glucose tolerance on day 90 after kidney transplantation—A prospective proof-of-concept study	20
OPTN/SRTR 2022 Annual Data Report: Preface	20
Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma	20
Impact of deceased organ donor marijuana use on donor culture positivity and solid organ transplant recipient outcomes	20
Nanoparticle targeting of neutrophil glycolysis prevents lung ischemia-reperfusion injury	20
Intraoperative blood pressure management during kidney transplantation: Grafts under pressure	20
Detection of viral RNA and DNA and immune response following administration of live attenuated measles and varicella vaccines in children with chronic liver disease	20
Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic	20
Effect of citizenship status on access to pediatric liver and kidney transplantation	20
Pediatric cardiac xenotransplantation and stakeholder engagement	20
Understanding the mechanisms and implications of the association between community distress and organ nonutilization	19
Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients	19